According to Codexis 's latest financial reports the company's total debt is $16.02 M. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $16.02 M | -63.28% |
2022-12-31 | $43.63 M | -8.43% |
2021-12-31 | $47.65 M | 90.99% |
2020-12-31 | $24.95 M | -4.47% |
2019-12-31 | $26.11 M | 5274.07% |
2018-12-31 | $0.48 M | -33.15% |
2017-12-31 | $0.72 M | 71.06% |
2016-12-31 | $0.42 M | 0% |
2015-12-31 | $0.42 M | 0% |
2014-12-31 | $0.42 M | |
2010-12-31 | $N/A | -100% |
2009-12-31 | $7.94 M | -41.95% |
2008-12-31 | $13.68 M | -21.41% |
2007-12-31 | $17.4 M | 327.38% |
2006-12-31 | $4.07 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $70.84 B | 442,018.07% | ๐บ๐ธ USA |
Merck MRK | $35.05 B | 218,665.60% | ๐บ๐ธ USA |
Dupont De Nemours DD | $7.74 B | 48,208.79% | ๐บ๐ธ USA |
Balchem BCPC | $0.33 B | 1,961.50% | ๐บ๐ธ USA |